Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lei Ye has a total of 118 co-authors. Here are the top co-authors by number of shared publications:

  • Hongwei Cheng

    Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China

    16 shared publications
  • Xuefei Ji

    Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China

    8 shared publications
  • Liao Guan

    Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University, China

    7 shared publications
  • Bohang Liu

    Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China

    5 shared publications
  • Ming Shan

    Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, P.R. China

    4 shared publications
  • Yangchun Hu

    Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People’s Republic of China

    4 shared publications

Latest Publications

  • Open Access

    Glymphatic dysfunction in drug-resistant epilepsy and its association with vagus nerve stimulation outcomes: a DTI-ALPS study

    by Ziao Xu, Xiaofeng Wang, Bohang Liu, Xuefei Ji, Ming Shan, Hongwei Cheng, Lei Ye

    Background: The glymphatic system (GS) is critical for interstitial fluid clearance and has been implicated in various neurological disorders. However, its role in drug-resistant epilepsy (DRE) and response to vagus nerve stimulation (VNS) remains unclear. Objectives: This study aimed to assess GS function in patients with DRE using diffusion tensor image analysis along the perivascular space (DTI-ALPS) and to explore its association with VNS outcomes. Design: Data from patients with DRE who underwent VNS were retrospectively analyzed at a single center. Methods: Forty patients with DRE and 30 healthy controls were enrolled. ALPS indices were calculated for the left (ALPS-L), right (ALPS-R), and bilateral (ALPS-B) hemispheres. The clinical outcomes after VNS were classified using McHugh outcome classification. Statistical comparisons and logistic regression were used to examine group differences and the predictive value of ALPS indices. Results: Compared to controls, patients with DRE exhibited significantly reduced ALPS-L ( p < 0.001) and ALPS-B ( p = 0.005) indices. Among patients with DRE, responders to VNS had significantly higher ALPS-R ( p = 0.021) and ALPS-B ( p = 0.027) indices than nonresponders. ALPS-L exhibited a positive trend ( p = 0.073). In logistic regression analyses, ALPS-R and ALPS-B were significantly associated with favorable VNS outcomes in univariate and multivariate models. After adjusting for age, sex, and disease duration, ALPS-L ( p = 0.028, odds ratio (OR) = 2.739), ALPS-R ( p = 0.020, OR = 2.802), and ALPS-B ( p = 0.020, OR = 3.241) all emerged as independent predictors of VNS response. Conclusion: Glymphatic dysfunction is present in DRE and may influence responsiveness to VNS. Higher ALPS indices predicted better treatment outcomes, supporting ALPS potential as a noninvasive imaging biomarker for presurgical stratification in epilepsy.


  • Open Access

    From cancer treatment strategies to survivorship care: Advances in integrating multi-omics and artificial intelligence

    by Ling Yin, Bao Chun Cheng, Xueyi Wang, Li Xia, Lei Ye, Xuefei Ji, Hui Wang, Lu Gao

    Advances in oncology are successfully shifting clinical focus beyond initial tumor control to address the complex, lifelong needs of a growing survivor population. This review examines the evolution of therapeutic paradigms, dissecting the mechanistic underpinnings and clinical impact of modern immunotherapies and gene-based modalities. It further addresses the multifaceted challenges in survivorship care, from managing persistent morbidity and psychological distress to overcoming systemic barriers in care coordination. Central to this discussion is the promise of multi-omics—which offers a high-resolution lens into tumor and host biology—to enable preemptive risk profiling. Concurrently, artificial intelligence (AI) emerges as the computational engine to distill these complex datasets into actionable intelligence for personalized surveillance. Furthermore, this review explores the translational hurdles facing AI, with a critical examination of inherent vulnerabilities, such as algorithmic bias, model opacity, and ethical pitfalls, in clinical deployment. By synthesizing these domains, this article provides a conceptual framework to steer the evolution of evidence-based, equitable, and patient-focused survivorship care.

  • The dynamic changes of serum levels of PD-1/PD-L1 correlate with the therapeutic effectiveness of antibiotics in patients with sepsis

    by Yan Li, Biran Ding, Lei Ye, Yuanbao Xu

    1. Sepsis continues to be a formidable global health crisis, representing a primary cause of mortality in intensive care units worldwide. It is defined as a life-threatening organ dysfunction resul...

  • Open Access

    Hippocampal T1WI radiomics- and clinical feature-based models for predicting early mild cognitive impairment in secondary hydrocephalus

    by Xiaofeng Wang, Ziao Xu, Bohang Liu, Xuefei Ji, Liao Guan, Lei Ye, Hongwei Cheng

    Introduction: Mild cognitive impairment (MCI) represents the initial stage of dementia, and early diagnosis is crucial in clinical practice. This study aimed to investigate the predictive performance of three models based on clinical features, radiomics features of hippocampal T1-weighted imaging, and a combination of these features for identifying MCI in patients with secondary hydrocephalus. Methods: Of the 378 patients with secondary hydrocephalus, 124 were ultimately included in the study and divided into two cohorts: those with Mild Cognitive Impairment (MCI, n = 49) and those without MCI ( n = 75). The samples were randomly stratified into a training set (34 MCI and 52 non-MCI patients) and a validation set (15 MCI and 23 non-MCI patients). Radiomic features from the bilateral hippocampi were extracted based on the region of interest, and the optimal parameters were selected through dimensionality reduction. Predictive models were constructed using clinical data, radiomic data, and a combination of both, with the radiomic score being utilized. The performance of each model was then assessed in both training and validation sets. Additionally, the diagnostic performance of the optimal model was compared with that of the Montreal Cognitive Assessment (MoCA) Scale. Results: In the clinical model, the disease course, serum uric acid, serum cystatin C, and the lateral ventricular temporal horn ratio emerged as independent risk factors for MCI following hydrocephalus. In the radiomics model, four optimal hippocampal features were identified. The AUC values for the clinical, radiomics, and combined models in the training/validation sets were 0.827 (0.736 ~ 0.919)/0.812 (0.666 ~ 0.957), 0.864 (0.790 ~ 0.937)/0.849 (0.724 ~ 0.974), and 0.937 (0.889 ~ 0.985)/0.907 (0.804 ~ 1.000), respectively. The combined model exhibited higher AUC values than the MoCA scale in both datasets. There was a significant difference in the training set, and while the validation set showed a consistent trend, it did not achieve statistical significance. Conclusion: The combined model achieved optimal performance and demonstrated superior predictive capabilities for MCI in the patients with secondary hydrocephalus outperforming other models.


  • Open Access

    Amino acid dysregulation in cerebrospinal fluid of stroke patients serving as diagnostic biomarkers in post-neurosurgical bacterial meningitis

    by Wei Chen, Yuanyuan Chen, Bohang Liu, Lu Ding, Chaojie Wang, Hongwei Cheng, Lei Ye

    Post-neurosurgical bacterial meningitis (PNBM) is a severe complication following neurosurgical operations. However, clinical diagnosis of PNBM is difficult because of the complicated pathological conditions. This study aims to investigate alterations in amino acid metabolism in hemorrhagic stroke patients with PNBM through targeted metabolomics analysis. Cerebrospinal fluid (CSF) samples were collected from 66 hemorrhagic stroke patients who underwent neurosurgical operation in our department. Baseline data were retrospectively analyzed for two patient groups: the post-neurosurgical bacterial meningitis group (PNBM, n = 40) and the non-post-neurosurgical bacterial meningitis (non-infected control group, n = 26), classified based on established diagnostic criteria for intracranial infection. A targeted analysis of 36 amino acids and their derivatives in CSF was performed using liquid chromatography-mass spectrometry (LC-MS). Candidate biomarkers were identified through Student’s t-test, fold change (FC) analysis, Variable Importance in Projection (VIP), and logistic Least Absolute Shrinkage and Selection Operator (LASSO) regression. The diagnostic performance was evaluated using Receiver Operating Characteristic (ROC) curve analysis. Twenty-one amino acids and their derivatives were found to be significantly downregulated in the PNBM group. Logistic LASSO regression identified Glycine (porginal=2.24 × 10−20, fold change = 0.34, AUC = 0.91), L-Threonine (porginal=5.05 × 10−28, fold change = 0.39, AUC = 0.92), and L-Homoserine (porginal=2.18 × 10−17, fold change = 0.28, AUC = 0.92) as potential biomarkers for diagnosing PNBM in the context of hemorrhagic stroke. Metabolic pathway analysis, corrected for false discovery rate, revealed three CSF-based amino acid metabolic pathways potentially associated with PNBM. In conclusion, these altered amino acids offer new insights into the pathophysiology of PNBM and providing helpful information on potential therapeutic targets in PNBM in the context of hemorrhagic stroke.


  • Anti-epileptic effect of saikosaponin a by inhibiting ferroptosis via the IL-17/Akt/ERK signaling pathway in the temporal lobe epilepsy model

    by Ping-Ping Li, Wen-Wen Wang, Jing-Tao Wang, Zi-Ao Xu, Xue-Fei Ji, Liao Guan, Lei Ye, Hong-Wei Cheng

    Saikosaponin A (SSa), a triterpenoid saponin isolated from Astragalus membranaceus, possesses multiple pharmacological properties, including anticonvulsant, antiepileptic, and anti-inflammatory activities. This study aimed to elucidate the molecular mechanisms by which SSa exerts therapeutic effects in temporal lobe epilepsy (TLE), with a particular focus on the involvement of ferroptosis pathways. In a kainic acid-induced TLE mouse model, electroencephalography (EEG) was used to monitor seizure frequency. Behavioral tests were employed to evaluate cognitive, learning, and memory functions. Additionally, molecular biology techniques were used to investigate the neuroprotective mechanisms of SSa. EEG recordings showed that SSa treatment significantly reduced seizure frequency and severity. Behavioral assessments indicated improvements in cognition, learning, and memory. Histological analysis revealed decreased neuronal death in the hippocampus. Transmission electron microscopy and Golgi-Cox staining demonstrated a marked increase in hippocampal neuron density following SSa treatment. At the cellular level, SSa significantly downregulated the expression of IL-17, phosphorylated Akt (p-Akt), and phosphorylated ERK (p-ERK) in Erastin-induced ferroptotic hippocampal neurons. Notably, the inhibitory effect of SSa on ferroptosis was reversed by IL-17 agonist treatment, suggesting that IL-17 plays a pivotal role in this pathway. In conclusion, SSa alleviates seizures and improves cognitive function in TLE by inhibiting IL-17/Akt/ERK-mediated ferroptosis in hippocampal neurons.

  • Open Access

    Downregulation of IL-20RA in Cerebrospinal Fluid Associated with the Risk of Moyamoya Disease: A Molecular Signatures Analysis with an Inflammation Proteomics Landscape

    by Chengdong Xia, Bohang Liu, Yangchun Hu, Hongwei Cheng, Lei Ye

    Purpose: Moyamoya disease (MMD) is a cerebrovascular disorder with diverse clinical manifestations. Surgical revascularization is currently the optimal choice in the treatment of MMD; however, it could not prevent the progression of the disease. Inflammation and immunity factors have been reported to play the pivotal role in the pathogenesis of MMD, but there were still limited studies concerning the inflammatory landscape. Here, we aimed to investigate the molecular signatures of MMD to outline the inflammatory feature of MMD. Patients and Methods: A total of 89 MMD patients and 93 healthy subjects were recruited for this study. We then divided all patients into screening cohort (15 MMD patients and 21 healthy subjects) and validation cohort (74 MMD patients and 72 healthy subjects). Proteomic analysis of the cerebrospinal fluid (CSF) was performed in the screening cohort, which contained 363 inflammation-related molecules. Then we used ELISA assay to validation of molecules of differential expression. Results: We screened 192 inflammation-related proteins that were differentially expressed in the CSF of MMD patients. Among that, 191 proteins were upregulated, while IL-20RA were downregulated (p=0.042). The bioinformatic analysis found a potential inflammatory landscape of MMD, offering clues for pathogenetic and therapeutic targets in the mechanistic study. We then validated that downregulation of IL-20RA in CSF was associated with the risk of MMD in the validation cohort. Conclusion: This study provided molecular signatures of MMD with a large-scale proteomic analysis of CSF. IL-20RA might be a key element in the pathogenesis of MMD.


  • Open Access

    Machine learning-based scoring model for predicting mortality in ICU-admitted ischemic stroke patients with moderate to severe consciousness disorders

    by Zhou Zhou, Bo Chen, Zhao-Jun Mei, Wei Chen, Wei Cao, En-Xi Xu, Jun Wang, Lei Ye, Hong-Wei Cheng

    Background: Stroke is a leading cause of mortality and disability globally. Among ischemic stroke patients, those with moderate to severe consciousness disorders constitute a particularly high-risk subgroup. Accurate predictive models are essential for guiding clinical decisions in this population. This study aimed to develop and validate an automated scoring system using machine learning algorithms for predicting short-term (3- and 7-day) and relatively long-term (30- and 90-day) mortality in this population.Methods: This retrospective observational study utilized data from the MIMIC-IV database, including 648 ischemic stroke patients with Glasgow Coma Scale (GCS) scores ≤12, admitted to the ICU between 2008 and 2019. Patients with GCS scores indicating speech dysfunction but clear consciousness were excluded. A total of 47 candidate variables were evaluated, and the top six predictors for each mortality model were identified using the AutoScore framework. Model performance was assessed using the area under the curve (AUC) from receiver operating characteristic (ROC) analyses.Results: The median age of the cohort was 76.8 years (IQR, 64.97–86.34), with mortality rates of 8.02% at 3 days, 18.67% at 7 days, 33.49% at 30 days, and 38.89% at 90 days. The AUCs for the test cohort’s 3-, 7-, 30-, and 90-day mortality prediction models were 0.698, 0.678, 0.724, and 0.730, respectively.Conclusion: We developed and validated a novel machine learning-based scoring tool that effectively predicts both short-term and relatively long-term mortality in ischemic stroke patients with moderate to severe consciousness disorders. This tool has the potential to enhance clinical decision-making and resource allocation for these patients in the ICU.


  • Transcranial resection of falcine meningiomas by complete endoscopy with the assistance of intraoperative ultrasound

    by Jin Xiao, Tianchen Zhao, Xiang Cheng, Qiang Sheng, Chao Li, Yan Li, Yiquan Zhang, Xianxiang Wang, Hongwei Cheng, Lei Ye

    Transcranial neurosurgery assisted by endoscopy and intraoperative ultrasound (IOUS) has become an effective approach for real-time visualization and guidance during tumor resection. This study explores the application of these techniques in falcine meningioma (FM) resection, assessing their feasibility and safety. Eleven FM patients underwent transcranial endoscopic resection with IOUS assistance. Preoperative neuroimaging, including magnetic resonance (MR) imaging, computed tomography, MR angiography, and MR venography, guided surgical planning. IOUS provided real-time tumor localization, boundary visualization, adjacent structure assessment, and guidance throughout the resection. Tumors were located in the anterior, middle, and posterior falx in 4, 5, and 2 patients, respectively. Of the 11 cases, 8 involved unilateral falx tumors and 3 involved bilateral falx tumors. Simpson grade 1 resection was achieved in 12 patients; one case involved a deeply located tumor closely associated with the deep venous plexus. Pathologically, 10 patients had World Health Organization (WHO) grade 1 meningiomas, and 1 had a WHO grade 3 anaplastic meningioma. Postoperative complications included temporary contralateral hemiplegia in one patient and pulmonary infection in another. The average follow-up period was 19.3 months, with all patients achieving Karnofsky Performance Status scores of > 90. In conclusion, endoscopic resection with IOUS assistance is both feasible and safe for FM patients.